Literature DB >> 16478521

Plasmid-mediated bacteriocin production by Shigella flexneri isolated from dysenteric diarrhoea and their transformation into Escherichia coli.

C Padilla1, O Lobos, P Brevis, P Abaca, E Hubert.   

Abstract

AIMS: To determine the production of bacteriocin by Shigella flexneri strains, to relate their production to the presence of dysenteric diarrhoea and to asses the genetic determination of the bacteriocin. METHODS AND
RESULTS: One hundred and sixteen strains of Sh. flexneri were isolated from patients with diarrhoea and 49 of them produced bacteriocin active against several Escherichia coli and abacteriocinogenic Sh. flexneri strains. The extrachromosomal DNA isolated from bacteriocinogenic Sh. flexneri strains were used as a substrate to transform E. coli HB-101 cells by means of electroporation.
CONCLUSIONS: Only the Sh. flexneri strains isolated from dysenteric diarrhoea produced bacteriocin. It was demonstrated that a plasmid of approx. 3 kb was responsible for the genetic determination of these anti-bacterial substances. SIGNIFICANCE AND IMPACT OF THE STUDY: A 3-kb plasmid that harboured information for the production of bacteriocin by Sh. flexneri strains was described. The production of this bacteriocin may be related to dysenteric diarrhoea produced by these bacterial strains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478521     DOI: 10.1111/j.1472-765X.2005.01829.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  8 in total

Review 1.  On the physiology and pathophysiology of antimicrobial peptides.

Authors:  Roland Pálffy; Roman Gardlík; Michal Behuliak; Ludevit Kadasi; Jan Turna; Peter Celec
Journal:  Mol Med       Date:  2008-11-10       Impact factor: 6.354

2.  Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.

Authors:  Mary C Rea; Clarissa S Sit; Evelyn Clayton; Paula M O'Connor; Randy M Whittal; Jing Zheng; John C Vederas; R Paul Ross; Colin Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-30       Impact factor: 11.205

Review 3.  When pathogenic bacteria meet the intestinal microbiota.

Authors:  Nathalie Rolhion; Benoit Chassaing
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-11-05       Impact factor: 6.237

4.  Evaluation of antibacterial activity of enterocin A-colicin E1 fusion peptide.

Authors:  Hadis Fathizadeh; Mahmood Saffari; Davoud Esmaeili; Rezvan Moniri; Morteza Salimian
Journal:  Iran J Basic Med Sci       Date:  2020-11       Impact factor: 2.699

5.  Partial Characterization of Novel Bacteriocin SF1 Produced by Shigella flexneri and Their Lethal Activity on Members of Gut Microbiota.

Authors:  Carlos Padilla; Verónica Carrasco-Sánchez; Andrés Padilla; Olga Lobos
Journal:  Int J Microbiol       Date:  2019-05-06

6.  Virulence, bacterocin genes and antibacterial susceptibility in Enterococcus faecalis strains isolated from water wells for human consumption.

Authors:  Carlos Padilla; Olga Lobos
Journal:  Springerplus       Date:  2013-02-09

7.  Colicin type 7 produced by majority of Shigella sonnei isolated from Thai patients with diarrhoea.

Authors:  Siriporn Kaewklom; Seksun Samosornsuk; Duangnate Pipatsatitpong; Ratchaneewan Aunpad
Journal:  Braz J Microbiol       Date:  2014-01-15       Impact factor: 2.476

8.  Shigella sonnei Does Not Use Amoebae as Protective Hosts.

Authors:  Jayne Watson; Claire Jenkins; Abigail Clements
Journal:  Appl Environ Microbiol       Date:  2018-04-16       Impact factor: 4.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.